Nerve News and Research

RSS

Small bioengineered implant promises long-lasting relief from Type 1 diabetes

People suffering from Type 1 diabetes are set to benefit from an innovative therapy being developed in an EU-funded project that promises to restore the body's ability to regulate blood sugar via a small bioengineered implant.

17 Jun 2019

Scientists improve working memory by extending brain signals

Researchers have discovered that short term memory can be improved by artificially extending neuronal signals called sharp wave ripples.

14 Jun 2019

New objective model classifies degrees of iridocorneal angle to assess severity of glaucoma

Pablo Amil, a researcher from the research group in Nonlinear Dynamics, Nonlinear Optics and Lasers (DNOLL) at the ESEIAAT, has created an objective model that classifies the degrees of the iridocorneal angle, a key element for assessing the severity of glaucoma.

14 Jun 2019

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.

13 Jun 2019

Study reveals how habitual smoking may contribute to development of hypertension

Smokers may be at a higher risk for developing hypertension, and an overactive response to normal drops in blood pressure may help explain why, according to researchers.

13 Jun 2019

Antibodies could cause arthritic pain

Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report.

13 Jun 2019

UK government to consider fortifying flour with folic acid to combat neural tube defects

A 12-week consultation has been launched to discuss whether folic acid should be added to flour in the UK.

13 Jun 2019

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Apolipoproten E is a major genetic risk factor for the development of Alzheimer's disease, yet the protein tends to be understudied as a potential druggable target for the mind-robbing neurodegenerative disease.

13 Jun 2019

Tetrodotoxin found in pufferfish can provide potent pain relief when given properly

Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.

13 Jun 2019

Transgenerational BPA exposure may contribute to autism, study finds

Transgenerational bisphenol A exposure may contribute to autism, according to a mouse study published in the Endocrine Society's journal Endocrinology.

12 Jun 2019

Study shows how fine motor tasks promote plastic reorganization of certain brain region

When we train the reaching for and grasping of objects, we also train our brain. In other words, this action brings about changes in the connections of a certain neuronal population in the red nucleus, a region of the midbrain.

12 Jun 2019

URMC biotech start-up receives funding to develop cell-based therapies for neurological disorders

Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders.

11 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Our tears may one day be used to detect glaucoma

Contrary to what many of us think, high pressure inside the eye does not define glaucoma and investigators want to know if the proteins circulating in the fluid of our eyes might.

10 Jun 2019

FDA authorizes marketing of first medical device for pain relief in adolescents with IBS

The U.S. Food and Drug Administration today permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome when combined with other therapies for IBS.

10 Jun 2019

Researchers one step closer to unmasking the cause of familial MS

A new study has uncovered mutations in 12 genes that may be responsible for the familial type of multiple sclerosis (MS).

7 Jun 2019

Researchers move closer to finding the root cause of MS

An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis.

7 Jun 2019

Kessler Foundation receives $1 million gift to study groundbreaking treatments for spinal cord injury

Tim Reynolds, co-founder of the Wall Street firm Jane Street Capital, and his wife, Caroline, made a $1 million gift to Kessler Foundation to launch groundbreaking research at the Foundation's new Center for Spinal Stimulation.

7 Jun 2019

Study provides new insight into how brain stem cells are activated

Our brains are notoriously bad at regenerating cells that have been lost through injury or disease. While therapies using neural stem cells (NSCs) hold the promise of replacing lost cells, scientists need to better understand how NSCs behave in the brain in order to develop effective treatments.

7 Jun 2019

Stress-induced changes in heart rate may impair auditory perception

Sudden hearing loss can be experienced in highly stressful situations, usually lasting a short time. Researchers at São Paulo State University in Brazil, collaborating with colleagues at Oxford Brookes University in the United Kingdom, have reported a discovery that contributes to a deeper understanding of this phenomenon.

7 Jun 2019

Nerve News and Research

Small bioengineered implant promises long-lasting relief from Type 1 diabetes

Scientists improve working memory by extending brain signals

New objective model classifies degrees of iridocorneal angle to assess severity of glaucoma

First clinical test could enable personalized prognosis for triple-negative breast cancer patients

Study reveals how habitual smoking may contribute to development of hypertension

Antibodies could cause arthritic pain

UK government to consider fortifying flour with folic acid to combat neural tube defects

Apolipoproten E appears to be new potential druggable target for Alzheimer's

Tetrodotoxin found in pufferfish can provide potent pain relief when given properly

Transgenerational BPA exposure may contribute to autism, study finds

Study shows how fine motor tasks promote plastic reorganization of certain brain region

URMC biotech start-up receives funding to develop cell-based therapies for neurological disorders

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Our tears may one day be used to detect glaucoma

FDA authorizes marketing of first medical device for pain relief in adolescents with IBS

Researchers one step closer to unmasking the cause of familial MS

Researchers move closer to finding the root cause of MS

Kessler Foundation receives $1 million gift to study groundbreaking treatments for spinal cord injury

Study provides new insight into how brain stem cells are activated

Stress-induced changes in heart rate may impair auditory perception

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News